All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Corline Biomedical AB revenue reports

Corline Biomedical AB financial reports, Corline Biomedical AB annual revenue in 2024. When does Corline Biomedical AB report revenue?
Add to widgets
Added to widgets

Corline Biomedical AB total revenue, net income and dynamics of changes in Swedish krona today

Net revenue Corline Biomedical AB is now 2 747 000 kr. Information about net revenue is taken from open sources. The dynamics of Corline Biomedical AB net revenue decreased by -2 762 000 kr from the last reporting period. The dynamics of Corline Biomedical AB net income fell by -1 350 000 kr for the last reporting period. The financial graph of Corline Biomedical AB displays the online status: net income, net revenue, total assets. Information on Corline Biomedical AB net income on the chart on this page is drawn in blue bars. The value of the "total revenue of Corline Biomedical AB" on the chart is marked in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 2 747 000 kr +19.64 % ↑ -1 405 000 kr -
31/12/2020 5 509 000 kr +36.4 % ↑ -55 000 kr -
30/09/2020 1 481 000 kr -31.657 % ↓ -2 150 000 kr -
30/06/2020 3 798 000 kr +11.02 % ↑ -2 575 000 kr -
31/12/2019 4 039 000 kr - -2 116 000 kr -
30/09/2019 2 167 000 kr - -1 932 000 kr -
30/06/2019 3 421 000 kr - -2 525 000 kr -
31/03/2019 2 296 000 kr - -2 967 000 kr -
Show:
to

Corline Biomedical AB financial report charts

The dates of the latest financial statements of Corline Biomedical AB: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Corline Biomedical AB for today is 31/03/2021. Gross profit Corline Biomedical AB is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Corline Biomedical AB is 2 312 000 kr

Corline Biomedical AB quarterly report dates

Cost of revenue Corline Biomedical AB is the total cost of producing and distributing of products and services of a company. Cost of revenue Corline Biomedical AB is 435 000 kr Total revenue Corline Biomedical AB refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Corline Biomedical AB is 2 747 000 kr Operating income Corline Biomedical AB is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Corline Biomedical AB is -1 405 000 kr

Net income Corline Biomedical AB is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Corline Biomedical AB is -1 405 000 kr Current assets Corline Biomedical AB is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Corline Biomedical AB is 21 591 000 kr Total assets Corline Biomedical AB refers to the total amount of assets owned by a person or entity. Total assets Corline Biomedical AB is 70 194 000 kr

31/03/2021 31/12/2020 30/09/2020 30/06/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 312 000 kr 4 378 000 kr 924 000 kr 2 532 000 kr 2 458 000 kr 1 302 000 kr 2 034 000 kr 1 353 000 kr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
435 000 kr 1 131 000 kr 557 000 kr 1 266 000 kr 1 581 000 kr 865 000 kr 1 387 000 kr 943 000 kr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 747 000 kr 5 509 000 kr 1 481 000 kr 3 798 000 kr 4 039 000 kr 2 167 000 kr 3 421 000 kr 2 296 000 kr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 4 039 000 kr 2 167 000 kr 3 421 000 kr 2 296 000 kr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-1 405 000 kr -55 000 kr -2 150 000 kr -2 575 000 kr -2 116 000 kr -1 932 000 kr -2 525 000 kr -2 967 000 kr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-1 405 000 kr -55 000 kr -2 150 000 kr -2 575 000 kr -2 116 000 kr -1 932 000 kr -2 525 000 kr -2 967 000 kr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 152 000 kr 5 564 000 kr 3 631 000 kr 6 373 000 kr 6 155 000 kr 4 099 000 kr 5 946 000 kr 5 263 000 kr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
21 591 000 kr 10 738 000 kr 10 095 000 kr 14 937 000 kr 24 993 000 kr 31 908 000 kr 35 547 000 kr 23 992 000 kr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
70 194 000 kr 58 282 000 kr 57 085 000 kr 60 779 000 kr 63 751 000 kr 66 060 000 kr 69 652 000 kr 58 006 000 kr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
19 427 000 kr 8 991 000 kr 7 847 000 kr 12 439 000 kr 22 857 000 kr 27 740 000 kr 32 898 000 kr 22 799 000 kr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 433 000 kr 4 626 000 kr 6 286 000 kr 6 011 000 kr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 4 433 000 kr 4 626 000 kr 6 286 000 kr 6 011 000 kr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 6.95 % 7 % 9.02 % 10.36 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
65 419 000 kr 52 032 000 kr 52 087 000 kr 54 237 000 kr 59 318 000 kr 61 434 000 kr 63 366 000 kr 51 995 000 kr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -275 000 kr -5 109 000 kr -3 704 000 kr -4 751 000 kr

Last revenue report of Corline Biomedical AB was 31/03/2021. According to last financial report total revenue in Corline Biomedical AB was 2 747 000 Swedish krona and changed by +19.64% since last year. Net income in Corline Biomedical AB was -1 405 000 kr in last quartal, net income changes to 0%.

Current cash Corline Biomedical AB - the sum of all of the cash a company has on the date of report. Current cash Corline Biomedical AB is 19 427 000 kr

Corline Biomedical AB stocks data

Corline Biomedical AB financials